PELLECCHIA, Maria Teresa
 Distribuzione geografica
Continente #
AS - Asia 16.808
NA - Nord America 10.677
EU - Europa 3.685
SA - Sud America 1.284
AF - Africa 157
OC - Oceania 90
Continente sconosciuto - Info sul continente non disponibili 3
Totale 32.704
Nazione #
HK - Hong Kong 11.109
US - Stati Uniti d'America 10.423
SG - Singapore 2.536
CN - Cina 1.152
BR - Brasile 947
VN - Vietnam 896
IT - Italia 881
RU - Federazione Russa 538
UA - Ucraina 530
DE - Germania 364
IE - Irlanda 291
FR - Francia 248
KR - Corea 206
TR - Turchia 199
SE - Svezia 195
IN - India 156
GB - Regno Unito 155
BD - Bangladesh 149
FI - Finlandia 140
AR - Argentina 126
CA - Canada 123
JP - Giappone 76
MX - Messico 73
PL - Polonia 61
NL - Olanda 54
AU - Australia 49
EC - Ecuador 47
CO - Colombia 46
IQ - Iraq 46
AT - Austria 45
EE - Estonia 38
ZA - Sudafrica 38
NZ - Nuova Zelanda 37
ID - Indonesia 35
PK - Pakistan 35
CZ - Repubblica Ceca 33
VE - Venezuela 33
ES - Italia 32
CL - Cile 25
UZ - Uzbekistan 25
KE - Kenya 22
PE - Perù 22
MA - Marocco 21
IL - Israele 20
PH - Filippine 20
SA - Arabia Saudita 20
PY - Paraguay 18
JM - Giamaica 15
MY - Malesia 15
JO - Giordania 12
TN - Tunisia 12
LT - Lituania 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
EG - Egitto 10
ET - Etiopia 10
UY - Uruguay 10
AZ - Azerbaigian 9
BO - Bolivia 9
LB - Libano 9
OM - Oman 9
DZ - Algeria 8
KZ - Kazakistan 8
BE - Belgio 7
CR - Costa Rica 7
HN - Honduras 7
NP - Nepal 7
DO - Repubblica Dominicana 6
GR - Grecia 6
PA - Panama 6
AL - Albania 5
BW - Botswana 5
KG - Kirghizistan 5
KH - Cambogia 5
TW - Taiwan 5
BG - Bulgaria 4
CY - Cipro 4
GT - Guatemala 4
LK - Sri Lanka 4
MN - Mongolia 4
NG - Nigeria 4
RS - Serbia 4
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
GE - Georgia 3
IR - Iran 3
LU - Lussemburgo 3
LV - Lettonia 3
LY - Libia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BH - Bahrain 2
BS - Bahamas 2
Totale 32.653
Città #
Hong Kong 11.090
Ann Arbor 1.422
San Jose 1.214
Singapore 1.206
Chandler 732
Princeton 707
Jacksonville 662
Wilmington 662
Ashburn 638
Dallas 513
Dublin 278
Dong Ket 270
Council Bluffs 267
Beijing 265
Houston 233
Woodbridge 233
The Dalles 223
Ho Chi Minh City 214
Lauterbourg 213
Nanjing 156
Izmir 154
Moscow 148
Hanoi 142
Andover 141
Boardman 128
Los Angeles 128
Naples 121
New York 120
Pellezzano 109
Dearborn 93
Salerno 90
São Paulo 86
Santa Clara 84
Tokyo 69
Norwalk 56
Düsseldorf 55
Munich 55
Fairfield 54
Montreal 51
Frankfurt am Main 50
Nanchang 49
Changsha 47
Hebei 46
Memphis 45
Shenyang 45
Warsaw 44
Redwood City 41
Tallinn 38
Jiaxing 36
Nuremberg 36
Rome 36
Pune 35
Da Nang 34
Rio de Janeiro 33
Brooklyn 32
Orem 32
San Francisco 31
Atlanta 28
Haiphong 28
Belo Horizonte 27
Buffalo 27
Chennai 27
Mestre 27
Chicago 26
Amsterdam 25
Milan 25
Seattle 25
Boston 24
Denver 23
Phoenix 23
Seoul 22
Brasília 21
Brno 21
Johannesburg 21
Tashkent 21
Washington 21
West Jordan 21
Curitiba 20
Stockholm 20
Nairobi 19
Columbus 18
Buenos Aires 17
Poplar 17
Turku 17
Auckland 16
Baghdad 16
Guayaquil 16
Helsinki 16
London 16
Porto Alegre 16
Tianjin 16
San Diego 15
Shanghai 15
Charlotte 14
Guarulhos 14
Hải Dương 14
Ribeirão Preto 14
Sydney 14
Ankara 13
Biên Hòa 13
Totale 24.641
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.191
Caregivers’ Burden in Parkinson’s Disease: A Study on Related Features and Attachment Styles 1.047
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 960
Sex Differences in Parkinson’s Disease: From Bench to Bedside 652
Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy 602
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 593
Gender differences in microRNA expression in levodopa-naive PD patients 560
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 547
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 506
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 468
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 392
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 373
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 356
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 356
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 335
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 325
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 322
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 315
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease 312
A novel phenotype in an Italian family with a rare progranulin mutation 305
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 295
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 270
Long-Range Auditory Functional Connectivity in Hearing Loss and Rehabilitation 264
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 242
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 222
Identifying Correlations among Biomedical Data through Information Retrieval Techniques 217
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 214
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 210
The natural history of multiple system atrophy: A prospective European cohort study 196
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 195
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 194
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 193
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin 192
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 183
Postganglionic sudomotor denervation in patients with multiple system atrophy. 182
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 179
Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort 178
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 171
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 169
A critique of the second consensus criteria for multiple system atrophy 168
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 167
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 164
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 163
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease. ICGBD 2022 : International Conference on Global Burden of Disease 161
Brain anatomical substrates of mirror movements in Kallmann syndrome. 160
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 158
Quitting smoking: An early non-motor feature of Parkinson's disease? 148
Increased bilirubin levels in de novo Parkinson's disease 148
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 148
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 147
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 145
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 145
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 142
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 142
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 140
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 140
Cortical pattern of reduced perfusion in hearing loss revealed by ASL-MRI 138
Adult-onset familial laryngeal abductor paralysis, cerebellar ataxia, and puremotor neuropathy 137
A genome-wide association study in multiple system atrophy 134
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 133
The development of appropriate strategies and methods for mutation analysis in the ATP7B gene 132
Sindromi parkinsoniane 132
Adult-onset pure tic disorder after post-traumatic hypoxic lesions of the globus pallidus 130
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. 129
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 128
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 127
Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 127
The relevance of gender in Parkinson's disease: a review 125
The alpha-synuclein gene in multiple system atrophy 125
The accuracy of the arginine growth hormone test in parkinsonism. 125
Gender and non motor fluctuations in Parkinson's disease: A prospective study 125
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 125
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 124
PINK1 heterozygous rare variants: Prevalence, significance and phenotypic spectrum 121
Cognitive correlates of “pure apathy” in Parkinson's disease 119
Cross-modal connectivity effects in age-related hearing loss 119
Early MRI findings in acquired hepatocerebral degeneration. 117
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 116
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 115
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 115
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 114
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 114
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 114
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration 114
Brain stem cystic astrocytoma presenting with "pure" parkinsonism 113
On the relationship between side of onset and cognition in Parkinson disease 113
SNCA variants are associated with increased risk for multiple system atrophy 112
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 112
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 112
“Response to Apomorphine in early Parkinson’s disease”. 112
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 112
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 111
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 110
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 108
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 107
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 107
PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts 107
A comparison of auditory and vestibular dysfunction in Parkinson's disease and Multiple System Atrophy 107
Observational study of sleep-related disorders in Italian patients with Parkinson's disease: usefulness of the Italian version of Parkinson's disease sleep scale. 106
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 106
Totale 22.298
Categoria #
all - tutte 101.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.922


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021322 0 0 0 0 0 0 0 0 0 0 0 322
2021/20221.112 5 7 5 6 13 4 24 37 171 160 136 544
2022/20231.846 209 129 69 174 257 412 14 161 284 11 89 37
2023/20241.225 67 153 62 93 51 136 61 120 87 79 110 206
2024/20253.209 147 35 65 158 159 318 418 342 507 303 379 378
2025/202619.880 3.032 5.189 4.284 697 1.263 609 1.844 420 606 1.158 405 373
Totale 33.330